Pain Phenotypes in Chronic Pancreatitis
NCT05713344 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2023-02-08
Summary
Chronic pancreatitis (CP) is characterised by recurrent abdominal pain. The pathological hallmarks of CP is pancreatic stellate cell activation that results in persistent inflammation and progressive fibrosis. It has been shown in various clinical and experimental studies that with disease progression there could be pancreatic neural inflammation, spinal sensitization and eventually alteration in the pain modulating architecture within the brain (widespread sensitization). These events result in different types of pain (nociceptive and neuropathic) in patients with CP, which may dynamically change during disease progression.
Since the treatment for different mechanisms are unique, it becomes important to identify the predominant type of pain. Recently, pancreatic quantitative sensory testing (P-QST) has emerged as a valuable tool to identify different types of sensitization. This facility is currently available only in select centers and is being conducted under research protocols.
In this study, we propose to: 1. evaluate the patterns of pain in CP and the triggers; 2. identify clinical surrogates of sensitization, i.e. neuropathic pain.
The ultimate goal is to apply the best possible pain management strategy based on our research findings for patients with CP in a personalised manner.
Conditions
- Chronic Pancreatitis
Interventions
- OTHER
-
Clinical history
Detailed clinical history including demographic details, pain details (character, pattern, location, change in character, involvement of new areas), duration of disease, co-morbidities, family history, adverse life events, sleep details, details of stress/anxiety.
- OTHER
-
Clinical examination
Thorough clinical examination, anthropometric measurement, assessment of pain (Izbicki score, Visual analog scale, modified brief pain inventory, pain catastrophising score, painDetect)
- OTHER
-
Evaluation of quality of life
Use of the EORTC QLQ c30 with PAN 28 to evaluate quality of life
- OTHER
-
Evaluation of mental state
Use of Beck depression inventory and Hospital Anxiety Depression score to evaluate depression and anxiety
- DIAGNOSTIC_TEST
-
Pancreatic quantitative sensory testing
Pancreatic quantitative sensory testing will be performed to evaluate temporal summation, pain detection threshold, pain tolerance threshold, and conditioned pain modulation.
Sponsors & Collaborators
-
All India Institute of Medical Sciences
collaborator OTHER -
SIDS Hospital and Research Center, Surat
collaborator UNKNOWN -
Aalborg University Hospital
collaborator OTHER -
Asian Institute of Gastroenterology, India
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-08-01
- Primary Completion
- 2023-02-28
- Completion
- 2023-02-28
Countries
- India
Study Locations
More Related Trials
-
Bowel Sound in Predicting the Severity of Acute Pancreatitis: Protocol of a Prospective, Multi-center Study
NCT06867120 ·Status: RECRUITING
-
The Application of the PDCA Management Model in Improving the Diagnostic Accuracy of AIG
NCT06557252 ·Status: NOT_YET_RECRUITING
-
Detection of Exocrine Pancreatic Insufficiency in Patients With Diarrhea and Bloating
NCT03407534 ·Status: COMPLETED
-
Gastric Pathophysiology in Diabetes
NCT06068114 ·Status: RECRUITING
-
Comparative Study of Epigastric Pain Syndrome and Postprandial Distress Syndrome
NCT00673972 ·Status: WITHDRAWN ·Phase: PHASE4
-
Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension
NCT02543658 ·Status: COMPLETED ·Phase: PHASE2
-
Follow-up Study of Small-intestinal Mucosal Injuries in Chronic Non-steroidal Anti-inflammatory Drugs (NSAIDs)-Users
NCT00854490 ·Status: UNKNOWN
-
Diagnostic Yeild of Esophagogastrodudenoscopy in Pediatric Chronic Abdominal Pain
NCT07154940 ·Status: NOT_YET_RECRUITING
-
Evaluation of Immunohistochemical Expression of Heparanase in Helicobacter Pylori-Associated Chronic Gastritis
NCT05073614 ·Status: COMPLETED ·Phase: NA
-
Gastropanel for Gastric Atrophy and Cancer Risk Assessment
NCT02114411 ·Status: UNKNOWN
-
Helicobacter Pylori Gastritis and Its Relation to Metabolic Syndrome Components
NCT06935955 ·Status: NOT_YET_RECRUITING
-
Natural History of Non-steroidal Anti-inflammatory Drug and Non-Helicobacter Pylori in Bleeding Peptic Ulcers
NCT00153712 ·Status: COMPLETED
-
Gastric Activity and Gastrointestinal Peptides in Patients With Functional Dyspepsia
NCT02113527 ·Status: COMPLETED
-
Correlation Among Various OLGA and OLGIM Stages, Digestive Symptom Scores, and Acupuncture Treatment in Patients with Chronic Atrophic Gastritis
NCT06707701 ·Status: NOT_YET_RECRUITING
-
Pyloric or Pseudopyloric Metaplasia of the Corpus Mucosa in Autoimmune Gastritis
NCT05238181 ·Status: ENROLLING_BY_INVITATION
-
COMPREHENSIVE ANALYSIS OF NUTRITIONAL PARAMETERS IN PATIENTS WITH IDIOPATHIC ACHALASIA: A PROSPECTIVE STUDY.
NCT05161923 ·Status: UNKNOWN
-
Acupuncture Treatment for Gastroparesis: a Pilot Study
NCT01643577 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Bio-electrical Impedance Analysis in Patients With Functional Dyspepsia
NCT07196735 ·Status: RECRUITING
-
Observational Study on Monitoring NSAID-Induced Gastropathy in Patients Using Magnetically-Controlled Capsule Gastroscopy
NCT06027060 ·Status: SUSPENDED
-
The Effect of Multiple Medications on the Incidence of Organic Dyspepsia
NCT05524675 ·Status: UNKNOWN
-
A Study to Evaluate the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary Dyspepsia
NCT07016269 ·Status: RECRUITING ·Phase: PHASE4
-
Symptom Assessment for GERD Patients Receiving H. Pylori Eradication
NCT01249482 ·Status: UNKNOWN
-
Exocrine Pancreatic Insufficiency and Functional Dyspepsia
NCT06756503 ·Status: NOT_YET_RECRUITING
-
Plasma Levels of Glucagon-like Peptide-2 and Dyspepsia in Patients With Extraintestinal Cancer During Chemotherapy
NCT01382667 ·Status: COMPLETED
-
Relationship Between Diet and Gastritis
NCT07129824 ·Status: NOT_YET_RECRUITING